Knowledge, attitudes, and practices regarding drug allergy among healthcare providers in Eastern India

Deependra Kumar Rai; Pramod Kumar Manjhi; Rathis Nair

doi:10.18203/2319-2003.ijbcp20231117

Authors

Deependra Kumar Rai Department of Pulmonary Medicine, All India Institute of Medical Sciences (AIIMS), Patna, Bihar, India
Pramod Kumar Manjhi Department of Pharmacology, All India Institute of Medical Sciences (AIIMS), Patna, Bihar, India
Rathis Nair College of Nursing, All India Institute of Medical Sciences (AIIMS), Patna, Bihar, India

DOI:

https://doi.org/10.18203/2319-2003.ijbcp20231117

Keywords:

Knowledge, Attitudes and practice, Drug allergy, Healthcare provider

Abstract

Background: Drug allergy (DA) or hypersensitivity is an immunologically mediated reaction producing stereotype symptoms which is challenging for health care providers (HCP). Objective of current study was to assess the knowledge, attitudes and practices of drug allergy among healthcare providers in eastern India.

Methods: A 25-item self-administered DA questionnaire was developed and applied in our study. The questionnaire covered 3 domains: knowledge, attitudes, and practice patterns. From July 2020 to September 2020, HCPs participated in the cross-sectional study.

Results: A total of 237 HCPs participated in the study, and all questionnaires were analysed.

Among the respondents, 226 (95.4%) were nurses, 9 (3.8%) were doctors and 2 (0.8%) were pharmacists. The majority of HCPs agreed that drug-induced immediate allergic reactions were IgE mediated 225 (94.9%), occur within 6 hours of drug administration (89.9%), and epinephrine was the first choice for drug-induced anaphylaxis (76.8%). 97.9% HCPs agreed that penicillin skin test was valuable to predict the allergic reaction. More than 80% of the respondents would take patients’ allergic history before drug administration, while 75.5% agreed that they recognize and manage drug allergy timely when it occurs.

Conclusions: Drug allergy was often diagnosed and managed inadequately, regardless of practice location, employment status and speciality in eastern India. The HCPs demonstrated a low level of knowledge regarding DA. Advanced education is urgently needed for better understanding and filling the gaps that exist in the knowledge and clinical practice of DA.

Metrics

Metrics Loading ...

References

Srinivasan R, Ramya G. Adverse drug reaction-Causality assessment. IJRPC. 2011;1:606-12.

Ghosh S, Leelavathi DA, Rao PM. Study and evaluation of various cutaneous adverse drug reactions in Kasturba Hospital, Manipal. Indian J Pharma Sci. 2006;68:212-5.

Nayak S, Acharjya B. Adverse cutaneous drug reaction. Indian J Dermatol. 2008;53:2-8.

Shinkai K, Stern RS, Wintroub BU. Cutaneous drug reactions. In: Longo DL, Fauci AS, Kasper DL, eds. Harrison’s principles of internal medicine. 18th ed. New York: McGraw-Hill Companies; 2012:432-40.

Sharma VK, Sethuraman G, Kumar B. Cutaneous adverse drug reactions: Clinical pattern and causative agents-A six-year series from Chandigarh, India. J Postgrad Med. 2001;47:95-9.

Naldi L, Conforti A, Venegoni M. Cutaneous reactions to drug: an analysis of spontaneous reports in four Italian regions. Br J Clin Pharmacol. 1999;48:839-46.

Gomes ER, Demoly P. Epidemiology of hypersensitivity drug reactions. Curr Opin Allergy Clin Immunol. 2005;5:309-16.

Greenberger PA. Drug allergy. J Allergy Clin Immunol. 2006;117(2):464-70.

Johansson SG, Bieber T, Dahl R. Revised nomenclature for allergy for global use. Report of the nomenclature review committee of the world allergy organization.. J Allergy Clin Immunol. 2004;113:832-6.

Wang Y. Knowledge, attitudes, and practices survey of drug allergy among healthcare practitioners in central China: a multicenter study. Asia Pac Allergy. 2016; 6:105-11.

Manjhi PK, Mohan L, Dikshit H, Mishra H, Kumar M, Dokania S. Cutaneous drug reactions notified by ADR monitoring centre in a tertiary care hospital of Bihar. Int J Basic Clin Pharmacol. 2017;6:80-4.

Gomes ER, Demoly P. Epidemiology of hypersensitivity drug reactions. Curr Opin Allergy Clin Immunol. 2005;5:309-16.

Tang R, Xu HY, Cao J, Chen S, Sun JL, Hu H, et al. Clinical characteristics of inpatients with anaphylaxis in China. Biomed Res Int. 2015;2015:429534.

Limsuwan T, Demoly P. Acute symptoms of drug hypersensitivity. Med Clin North Am. 2010;94:691-710.

Aberer W, Bircher A, Romano A, Blanca M, Campi P, Fernandez J, et al. European Network for Drug Allergy (ENDA). EAACI interest group on drug hypersensitivity. Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations. Allergy. 2003;58:854-63.

Brockow K, Garvey LH, Aberer W, Atanaskovic-Markovic M, Barbaud A, Bilo MB, et al. ENDA/EAACI Drug Allergy Interest Group. Skin test concentrations for systemically administered drugs: an ENDA/EAACI Drug Allergy Interest Group position paper. Allergy. 2013;68:702-12.

Simons FE, Ardusso LR, Bilò MB, Dimov V, Ebisawa M, El-Gamal YM, et al. World Allergy Organization. 2012 Update: World Allergy Organization Guidelines for the assessment and management of anaphylaxis. Curr Opin Allergy Clin Immunol. 2012; 12:389-99.

Simons FE, Ardusso LR, Bilo MB, El-Gamal YM, Ledford DK, Ring J, et al. World Allergy Organization anaphylaxis guidelines: summary. J Allergy Clin Immunol. 2011;127:587-93.

Brockow K, Romano A, Blanca M, Ring J, Pichler W, Demoly P. General considerations for skin test procedures in the diagnosis of drug hypersensitivity. Allergy. 2002;57:45-51.

Bousquet PJ, Gaeta F, Bousquet-Rouanet L, Lefrant JY, Demoly P, Romano A. Provocation tests in diagnosing drug hypersensitivity. Curr Pharm Des. 2008;14:2792-802.

Wei X, Xie Y, Wang Y. Skin test: guide of post-marketed re-evaluation of clinical safety in traditional Chinese medicine injection. Zhongguo Zhong Yao Za Zhi. 2011;36:2877-9.

Grossman SL, Baumann BM, Garcia Peña BM, Linares MY, Greenberg B, Hernandez-Trujillo VP. Anaphylaxis knowledge and practice preferences of pediatric emergency medicine physicians: a national survey. J Pediatr. 2013;163:841-6.